Anesthesia; Functional Completed Phase 4 Trials for Neostigmine (DB01400)
Indication | Status | Phase |
---|---|---|
DBCOND0051867 (Anesthesia; Functional) | Completed | 4 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT02455921 | Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children | Screening |